Literature DB >> 2258416

Radiochromatography in pharmaceutical and biomedical analysis.

A C Veltkamp1.   

Abstract

Recent advances in the chromatographic analysis of radiolabelled compounds are discussed, with emphasis on the optimization of radioactivity detection in modern chromatographic techniques. Applications are mentioned only infrequently. The state-of-the-art of common radioactivity detection methods is reviewed, as well as promising new detection principles. The latter include flow-through liquid scintillation counting of reversed-phase column eluates based on post-column extraction and solvent segmentation, flow-through heterogeneous counting using a flow cell constructed from axially aligned scintillation fibres, flow cells especially constructed for the detection of beta-emitting radioisotopes in capillary zone electrophoresis, position-sensitive analysers employed in radio planar chromatography and, finally 14C atom counting (as opposed to 14C decay counting) by accelerator mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258416     DOI: 10.1016/s0378-4347(00)82282-3

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile.

Authors:  T Wikberg; A Vuorela
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

3.  A LabVIEW®-based software for the control of the AUTORAD platform: a fully automated multisequential flow injection analysis Lab-on-Valve (MSFIA-LOV) system for radiochemical analysis.

Authors:  Donato Barbesi; Víctor Vicente Vilas; Sylvain Millet; Miguel Sandow; Jean-Yves Colle; Laura Aldave de Las Heras
Journal:  J Radioanal Nucl Chem       Date:  2017-05-22       Impact factor: 1.371

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.